» » »

Cell Protein and Malignancy Chico CA

STAT3, which has a role in the cell nucleus regulating gene expression, is also present in the mitochondria of cells and regulates the electron transport chain in tumor cells in Chico.

Steven A Wahlen
(530) 891-8787
265 Cohasset Rd
Chico, CA
Specialty
Radiation Oncology

Data Provided by:
David C Potter
(530) 893-2323
265 Cohasset Rd
Chico, CA
Specialty
Medical Oncology

Data Provided by:
Edward John Ordorica, MD
(530) 332-3917
265 Cohasset Rd Ste 140
Chico, CA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1978

Data Provided by:
Anne Kathleen Dawson, MD
(530) 332-3917
265 Cohasset Rd Ste 140
Chico, CA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of Edinburgh Med Sch, Edinburgh, Scotland (803-03 Pr 1/71)
Graduation Year: 1976

Data Provided by:
Steven Allan Wahlen, MD
(530) 332-3917
265 Cohasset Rd Ste 140
Chico, CA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Loma Linda Univ Sch Of Med, Loma Linda Ca 92350
Graduation Year: 1989

Data Provided by:
David Charles Potter, MD
(530) 893-2323
265 Cohasset Rd Ste 170
Chico, CA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ca, San Francisco, Sch Of Med, San Francisco Ca 94143
Graduation Year: 1976

Data Provided by:
Sam Mazj
(530) 893-2323
265 Cohasset Rd
Chico, CA
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Scott B Schneider, MD
(360) 944-9889
135 Mission Ranch Blvd
Chico, CA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Ca, Los Angeles, Ucla Sch Of Med, Los Angeles Ca 90024
Graduation Year: 1991

Data Provided by:
John R Howard
(530) 893-2323
265 Cohasset Rd
Chico, CA
Specialty
Hematology

Data Provided by:
Grace E Yuh
(530) 891-8787
265 Cohasset Rd
Chico, CA
Specialty
Radiation Oncology

Data Provided by:
Data Provided by:

Cell Protein and Malignancy

Provided By:

A protein called STAT3 plays a major role in the change of normal cells into cancerous cells, according to U.S. researchers, who say the finding could lead to new cancer treatments.

STAT3, which has a role in the cell nucleus regulating gene expression, is also present in the mitochondria of cells and regulates the electron transport chain in tumor cells, said the study's leader, David E. Levy, a professor of pathology and microbiology at New York University's Langone Medical Center.

Mitochondria -- the energy source in cells -- are known to be critical to tumor cell metabolism.

"These results open the possibility that inhibiting the mitochondrial function of STAT3 could be a promising cancer therapy in the future," Levy said in a news release from the university's medical school.

"By knowing this mitochondrial function is critical, it may be possible to design therapeutic strategies that specifically target this function while sparing the other functions of the protein, such as its ability to turn genes on," he explained. "Therefore, we would hope that inhibitors could be developed that would be highly specific for cancer cells."

Levy and his team made the discovery about the mitochondrial role of STAT3 by analyzing tumors caused by the Ras oncogene, which has been determined to be involved in many human cancers.

A report on the findings appears in the June 26 issue of Science.

"Future experiments will need to determine if a similar mitochondrial role for STAT3 is critical for other types of cancer as well," Levy said. "We'll also need a better understanding of the biochemical basis for the function of STAT3. For instance, we are trying to find out what STAT3 does in mitochondria, what enzymes and processes it regulates and how these processes differ in tumors compared to normal cells."

More information

The U.S. National Cancer Institute has more about cancer.

SOURCE: NYU School of Medicine, news release, June 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com